| # | Title | Journal | Year | Citations |
|---|
| 1 | Bioavailability of Curcumin: Problems and Promises | Molecular Pharmaceutics | 2007 | 4,138 |
| 2 | Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles | Molecular Pharmaceutics | 2008 | 2,993 |
| 3 | Pharmacokinetics and Biodistribution of Nanoparticles | Molecular Pharmaceutics | 2008 | 1,313 |
| 4 | The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic | Molecular Pharmaceutics | 2009 | 884 |
| 5 | Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution | Molecular Pharmaceutics | 2008 | 870 |
| 6 | The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State | Molecular Pharmaceutics | 2007 | 844 |
| 7 | Nanomedicine(s) under the Microscope | Molecular Pharmaceutics | 2011 | 815 |
| 8 | Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents | Molecular Pharmaceutics | 2005 | 814 |
| 9 | pH-Responsive Nanoparticles for Drug Delivery | Molecular Pharmaceutics | 2010 | 806 |
| 10 | RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis | Molecular Pharmaceutics | 2012 | 785 |
| 11 | Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification | Molecular Pharmaceutics | 2004 | 691 |
| 12 | Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats | Molecular Pharmaceutics | 2008 | 605 |
| 13 | Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease | Molecular Pharmaceutics | 2013 | 584 |
| 14 | Applications of Deep Learning in Biomedicine | Molecular Pharmaceutics | 2016 | 535 |
| 15 | Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview | Molecular Pharmaceutics | 2008 | 529 |
| 16 | Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use | Molecular Pharmaceutics | 2009 | 512 |
| 17 | A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan | Molecular Pharmaceutics | 2006 | 493 |
| 18 | Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment | Molecular Pharmaceutics | 2011 | 422 |
| 19 | Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells | Molecular Pharmaceutics | 2009 | 416 |
| 20 | Biophysical Interactions with Model Lipid Membranes: Applications in Drug Discovery and Drug Delivery | Molecular Pharmaceutics | 2009 | 412 |
| 21 | Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery | Molecular Pharmaceutics | 2009 | 405 |
| 22 | Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data | Molecular Pharmaceutics | 2016 | 405 |
| 23 | Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor | Molecular Pharmaceutics | 2008 | 400 |
| 24 | 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics | Molecular Pharmaceutics | 2015 | 398 |
| 25 | Cocrystal or Salt: Does It Really Matter? | Molecular Pharmaceutics | 2007 | 389 |
| 26 | druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico | Molecular Pharmaceutics | 2017 | 384 |
| 27 | Gold Nanoparticles in Cancer Treatment | Molecular Pharmaceutics | 2019 | 371 |
| 28 | Carbon Nanohorns as Anticancer Drug Carriers | Molecular Pharmaceutics | 2005 | 369 |
| 29 | Physiological Parameters for Oral Delivery and in Vitro Testing | Molecular Pharmaceutics | 2010 | 364 |
| 30 | Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms | Molecular Pharmaceutics | 2008 | 363 |
| 31 | Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State | Molecular Pharmaceutics | 2014 | 360 |
| 32 | Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature | Molecular Pharmaceutics | 2010 | 347 |
| 33 | Nanotheranostics and Image-Guided Drug Delivery: Current Concepts and Future Directions | Molecular Pharmaceutics | 2010 | 344 |
| 34 | Drug-Loaded Carbon Nanohorns: Adsorption and Release of Dexamethasone in Vitro | Molecular Pharmaceutics | 2004 | 328 |
| 35 | Overcoming Nonviral Gene Delivery Barriers: Perspective and Future | Molecular Pharmaceutics | 2013 | 327 |
| 36 | Methotrexate Conjugated to Gold Nanoparticles Inhibits Tumor Growth in a Syngeneic Lung Tumor Model | Molecular Pharmaceutics | 2007 | 326 |
| 37 | Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels | Molecular Pharmaceutics | 2011 | 324 |
| 38 | Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability | Molecular Pharmaceutics | 2011 | 314 |
| 39 | Enhanced Antiproliferative Activity of Transferrin-Conjugated Paclitaxel-Loaded Nanoparticles Is Mediated via Sustained Intracellular Drug Retention | Molecular Pharmaceutics | 2005 | 311 |
| 40 | Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging | Molecular Pharmaceutics | 2006 | 310 |
| 41 | An Overview of Pharmaceutical Cocrystals as Intellectual Property | Molecular Pharmaceutics | 2007 | 309 |
| 42 | Mechanisms of Nanoparticle Internalization and Transport Across an Intestinal Epithelial Cell Model: Effect of Size and Surface Charge | Molecular Pharmaceutics | 2014 | 308 |
| 43 | Shrinkage of a Rapidly Growing Tumor by Drug-Loaded Polymersomes: pH-Triggered Release through Copolymer Degradation | Molecular Pharmaceutics | 2006 | 305 |
| 44 | The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles | Molecular Pharmaceutics | 2010 | 302 |
| 45 | Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and Naproxen | Molecular Pharmaceutics | 2011 | 302 |
| 46 | 3-D Tumor Model forIn VitroEvaluation of Anticancer Drugs | Molecular Pharmaceutics | 2008 | 299 |
| 47 | RGD-Conjugated Dendrimer-Modified Gold Nanorods for in Vivo Tumor Targeting and Photothermal Therapy | Molecular Pharmaceutics | 2010 | 294 |
| 48 | Dendrimers as Drugs: Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention | Molecular Pharmaceutics | 2005 | 288 |
| 49 | Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations | Molecular Pharmaceutics | 2006 | 288 |
| 50 | Screening for Pharmaceutical Cocrystal Hydrates via Neat and Liquid-Assisted Grinding | Molecular Pharmaceutics | 2007 | 288 |
